Rivastigmine transdermal system receives FDA approval for Alzheimer's disease

被引：0
|
作者：
Ralat, Jose
机构：
来源：
CNS SPECTRUMS | 2007年 / 12卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：581 / 582
页数：2
相关论文
共 50 条
  • [31] Rivastigmine for Alzheimer's disease
    Birks, Jacqueline S.
    Chong, Lee Yee
    Evans, John Grimley
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (09):
  • [32] Rivastigmine for Alzheimer's disease
    Birks, Jacqueline S.
    Evans, John Grimley
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (04):
  • [33] FDA Approval of Aduhelm Paves a New Path for Alzheimer's Disease
    Tanzi, Rudolph E.
    Rose, Joseph. P.
    Kennedy, F.
    ACS CHEMICAL NEUROSCIENCE, 2021, 12 (15): : 2714 - 2715
  • [34] Agents at the Peak of US FDA Approval for the Treatment of Alzheimer's Disease
    Alam, Jahngeer
    Kalash, Anushka
    Hassan, Md Imtaiyaz
    Rahman, Syed Ziaur
    NEUROLOGICAL RESEARCH, 2024, 46 (04) : 318 - 325
  • [35] FDA approval for Biogen’s aducanumab sparks Alzheimer disease firestorm
    Asher Mullard
    Nature Reviews Drug Discovery, 2021, 20 : 496 - 496
  • [36] FDA approval for Biogen's aducanumab sparks Alzheimer disease firestorm
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (07) : 496 - 496
  • [37] Rivastigmine Transdermal Patch and Physical Exercises for Alzheimer's Disease: A Randomized Clinical Trial
    Aguiar, Paula
    Monteiro, Larissa
    Feres, Ana
    Gomes, Irenio
    Melo, Ailton
    CURRENT ALZHEIMER RESEARCH, 2014, 11 (06) : 532 - 537
  • [38] Drug Profile: Transdermal Rivastigmine Patch in the Treatment of Alzheimer Disease
    Emre, Murat
    Bernabei, Roberto
    Blesa, Rafael
    Bullock, Roger
    Cunha, Luis
    Daniels, Hugo
    Dziadulewicz, Edward
    Foerstl, Hans
    Froelich, Lutz
    Gabryelewicz, Tomasz
    Levin, Oleg
    Lindesay, James
    Martinez-Lage, Pablo
    Monsch, Andreas
    Tsolaki, Magda
    van Laar, Teus
    CNS NEUROSCIENCE & THERAPEUTICS, 2010, 16 (04) : 246 - 253
  • [39] Controlled delivery of rivastigmine using transdermal patch for effective management of alzheimer's disease
    Malaiya, Mayank Kumar
    Jain, Ashish
    Pooja, Hurkat
    Jain, Anki
    Jain, Dharmendra
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2018, 45 : 408 - 414
  • [40] Rivastigmine Transdermal PatchIn the Treatment of Dementia of the Alzheimer’s Type
    Lily P. H. Yang
    Gillian M. Keating
    CNS Drugs, 2007, 21 : 957 - 965
12345